ClinicalTrials.Veeva

Menu

Diastolic Ventricular Interaction and the Effects of Biventricular Pacing in Hypertrophic Cardiomyopathy

U

University Hospitals Birmingham NHS Foundation Trust (UHB)

Status and phase

Unknown
Phase 3

Conditions

Hypertrophic Cardiomyopathy

Treatments

Device: Cardiac Resynchronisation Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT00698074
05/Q2709/64

Details and patient eligibility

About

The primary aim of this study will be to assess whether Biventricular pacing improves exercise capacity, and Quality of Life in patients with symptomatic drug resistant Non-Obstructive Hypertrophic Cardiomyopathy, using a Biventricular pacemaker.

Enrollment

32 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Symptomatic Hypertrophic Cardiomyopathy,

Exclusion criteria

  • Rhythm other than normal sinus Left ventricular outflow tract gradient greater than 30mmHg Inability to exercise v02 max greater than 70% of predicted.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

32 participants in 1 patient group

1
Experimental group
Description:
Cardiac Resynchronisation Therapy
Treatment:
Device: Cardiac Resynchronisation Therapy

Trial contacts and locations

1

Loading...

Central trial contact

Michael P Frenneaux, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems